FDA approves drug without evidence it works

Under pressure from families of patients with muscular dystrophy, the FDA approved a drug for this condition despite the lack of evidence it works.  The drug targets a gene mutation that affect 13% of boys with this condition.  The drug costs ~$300,000 a year.  [Daily Mail UK Sept 19, 2016]

In a recent animal study the combination of the red wine molecule resveratrol + the amino acid taurine and a botanical extract (apocynin) worked as well as prednisone (steroids) which is the current standard of care for muscular dystrophy. [Pharmacological Research April 2016]  There is sufficient scientific evidence to safely use resveratrol for patients with muscular dystrophy today. [Pubmed.gov]

Leave a Reply

Your email address will not be published. Required fields are marked *